Queen's Award Received in 2021 ISO 9001 Certified Delivered over 1,000,000 bio-reagents to life science researchers Trusted by Life Science Communities
Page Not Found
Cart summary

You have no items in your shopping cart.

Mitomycin C

SKU: orb422198

Description

Mitomycin C is a DNA crosslinking agent that inhibits DNA synthesis and induces apoptosis in a variety of cells.

Research Area

Cell Biology, Stem Cell & Developmental Biology

Images & Validation

Key Properties

CAS Number50-07-7
MW334.3
Purity>98%
FormulaC15H18N4O5
SMILESNC(OC[C@@H]1C2C(C(=C(C(=O)C=2N2C[C@@H]3N[C@@H]3[C@]12OC)C)N)=O)=O
TargetDNA
SolubilitySoluble in DMSO (up to 15 mg/ml) or in Water (up to 1 mg/ml).

Storage & Handling

Storage-20°C
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Similar Products

  • RAD51-IN-9 [orb2944918]

    103056-35-5

    292.718

    C14H13ClN2O3

    10 mg, 50 mg
  • Eponemycin [orb3024808]

    126509-46-4

    398.494

    C20H34N2O6

    50 mg, 10 mg
  • Mitomycin C [orb3027145]

    99.35% (May vary between batches)

    50-07-7

    334.37

    C15H18N4O5

    1 ml x 10 mM (in DMSO), 1 mg, 5 mg, 50 mg, 10 mg, 25 mg
  • Decarbamoylmitomycin C [orb3028523]

    26909-37-5

    291.302

    C14H17N3O4

    10 mg, 50 mg
  • Apaziquone hydroquinone [orb2815718]

    1177895-58-7

    290.31

    C15H18N2O4

    50 mg, 10 mg
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Key Properties

No computed properties available.

Protocol Information

David Giraldos 1, Evelyn Galano-Frutos 1, Laura Cambronero-Arregui 1, Manuel Beltrán Visiedo 1, Eduardo Romanos 2, Chantal Reina-Ortiz 1, Gemma Azaceta 3, Beatriz Martínez-Lázaro 3, Bárbara Menéndez-Jándula 4, Alejandro García-Romero 5, Francisco Javier Jiménez-Albericio 5 6, Isabel Marzo 1, Javier Naval 1, Alberto Anel 1 NK92 cells stably transfected with CD16 are efficient against multiple myeloma cells ex vivo and in vivo, especially if combined with daratumumab Oncoimmunology, (2025)

Available Sizes

Select a size below

5 mg
$ 180.00
25 mg
$ 340.00
DispatchUsually dispatched within 5-10 working days
Bulk Enquiry